Ganciclovir therapy for congenital cytomegalovirus infection in newborn infants: a meta analysis

HU Jin-Tao; CHEN Ping-Yang; XIE Zong-De; DANG Xi-Qiang; WANG Tao; HE Xiao-Ri; LI Wen; BO Tao

PDF(1272 KB)

Chinese Journal of Contemporary Pediatrics ›› 2010, Vol. 12 ›› Issue (1) : 35-39.

EVIDENCE-BASED MEDICINE

Ganciclovir therapy for congenital cytomegalovirus infection in newborn infants: a meta analysis

HU Jin-Tao, CHEN Ping-Yang, XIE Zong-De, DANG Xi-Qiang, WANG Tao, HE Xiao-Ri, LI Wen, BO Tao

Author information +

History +

Abstract

OBJECTIVE: To evaluate the efficacy and safety of ganciclovir therapy for congenital cytomegalovirus (CMV) infection in newborn infants. METHODS: The randomized controlled trials (RCTs) and quasi-RCTs on ganciclovir therapy for congenital CMV were reviewed in the following electronic databases: PubMed (January 1988 to January 2009), EMbase (January 1988 to January 2009), the Cochrane library (Issue 3, 2003 and Issue 1, 2009), the Chinese Journals Full-text Database (January 1994 to January 2009), the Chinese Biological Medical Disc (January 1994 to January 2009) and the Chinese Medical Current Contents (January 1994 to January 2009). Quality assessment, data extraction, and meta analysis were performed. RESULTS: Ten papers were included. Meta analysis showed that the ganciclovir therapy increased the improvement rate (91.4% vs 34.0%; P<0.01) and led CMV infection indexes to become negative in more patients (87.6% vs 15.3%; P<0.01) and decreased incidence of hearing disturbance (4.7% vs 37.2%; P<0.01) as compared with the non-ganciclovir therapy control group. The incidence of the ganciclovir-therapy-related side effects was low. CONCLUSIONS: Ganciclovir treatment may increase the improvement rate and the rate of CMV infection indexes becoming negative, and decrease incidence of hearing disturbance, with few side effects, in newborn infants with CMV infection. However the supporting evidence is not strong due to few trials and more high-quality research is needed.［Chin J Contemp Pediatr, 2010, 12 (1):35-39］

Key words

Congenital cytomegalovirus infection / Ganciclovir / Newborn infant

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

HU Jin-Tao, CHEN Ping-Yang, XIE Zong-De, DANG Xi-Qiang, WANG Tao, HE Xiao-Ri, LI Wen, BO Tao. Ganciclovir therapy for congenital cytomegalovirus infection in newborn infants: a meta analysis[J]. Chinese Journal of Contemporary Pediatrics. 2010, 12(1): 35-39

References

［1］Lagasse N, Dhooge I, Govaert P. Congenital CMV-infection and hearing loss［J］. Acta Otorhinolaryngol Belg, 2000, 54（4）：431-436.
［2］Boppana SB, Fowler KB, Vaid Y, Hedlund G, Stagno S, Britt WJ, et al. Neuroradiographic findings in the newborn period and long-term outcome in children with symptomatic congenital cytomegalovirus infection［J］. Pediatrics，1997，99（3）：409-414.
［3］金汉珍，黄德珉，官希吉. 实用新生儿学［M］. 第3版.北京：人民卫生出版社，2003：320-323.
［4］贺晓日，陈平洋，王涛，谢宗德，胡劲涛，薄涛，等.不同剂量更昔洛韦治疗新生儿先天性巨细胞病毒感染的临床观察［J］. 中国当代儿科杂志，2009，11（8）：641-644.
［5］吴婉芳. 围产期巨细胞病毒感染的诊断和治疗［J］. 中华儿科杂志，2001，39（11）：698-699.
［6］陈平洋，谢宗德，王涛. 更昔洛韦治疗新生儿先天性巨细胞病毒感染的临床研究［J］. 中国医师杂志，2003，5（4）：502-504.
［7］陈平洋，贺晓日，王涛，邱梅冰，闫淑媛，杨成华，等. 新生儿先天性巨细胞病毒感染的临床研究［J］. 实用儿科临床杂志，2007，22（22）：1697-1698.
［8］中华医学会儿科学分会感染消化学组. 巨细胞病毒感染诊断方案［J］. 中华儿科杂志，1999，37（7）：441.
［9］Halwachs-Baumann G，Genser B，Danda M，Engele H，Rosegger H，F-lsch B，et al. Screening and diagnosis of congenital cytomegalovirus infection：a 5-y study［J］. Scand J Infect Dis，2000，32（2）：137-142.
［10］Ross SA，Boppana SB. Congenital cytomegalovirus infection：outcome and diagnosis［J］. Semin Pediatr Infect Dis，2005，16（1）：44-49.
［11］董淮富，潘家华，李莉，李兴武. 更昔洛韦治疗先天性巨细胞病毒感染疗效观察［J］. 蚌埠医学院学报，2004，29（3）：228-230.
［12］邓学灵，石少连，何彩云. 更昔洛韦治疗新生儿先天性巨细胞病毒感染临床分析［J］. 现代医药卫生，2005，21（14）：1805.
［13］杨晶，史湘英，骆萍. 更昔洛韦治疗新生儿巨细胞病毒感染66例［J］. 航空航天医药，2007，18（2）：79-80.
［14］王崇伟，许植之，周晓玉，赵卫华，蒋小镛，毛红霞. 更昔洛韦联合丙种球蛋白治疗加早期干预对新生儿巨细胞病毒感染脑损伤的影响［J］. 南京医科大学学报（自然科学版），2007，27（4）：326-328.
［15］郑忠实，黄恩娥. 先天性巨细胞病毒感染35例临床分析［J］. 中国新生儿科杂志，2008，23（2）：109-110.
［16］高成菊. 更昔洛韦联合丙种球蛋白治疗先天性巨细胞病毒感染［J］. 吉林医学，2008，29（3）：194-195.
［17］Kimberlin DW, Lin CY, Sanchez PJ, Demmler GJ, Dankner W, Shelton M, et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial［J］. J Pediatr，2003，143（1）：16-25.
［18］Lackner A, Acham A, Alborno T, Moser M, Engele H, Raggam RB, et al. Effect on hearing of ganciclovir therapy for asymptomatic congenital cytomegalovirus infection: four to 10 year follow up［J］. J Laryngol Otol，2009，123（4）：391-396.
［19］Bueno J，Ramil C，Green M. Current management strategies for the prevention and treatment of cytomegalovirus infection in pediatric transplant recipients［J］. Paediatr Drugs，2002，4（5）：279-290.
［20］胡劲涛，谢宗德，陈平洋，曹甜，刘嘉，贺晓日，等. 先天性巨细胞病毒感染患儿听力障碍研究［J］. 临床耳鼻咽喉头颈外科杂志，2007，21（19）：897-898.
［21］Fowler KB，Boppana SB. Congenital cytomegalovirus（CMV） infection and hearing deficit ［J］. J Clin Virol，2006，35（2）：226-231.